|
|
| (11) | Number of the document | |
| (68) | Number of the document | 3409274 |
| (21) | Application number for Supplementary Protection Certificate | PA 2020 005 |
| (22) | Date of filing the application | 2020-11-17 |
| (41) | Date of publication of the application | 2020-12-10 |
| Date of publication of SPC | ||
| (24) | Date of coming into effect of SPC |
| (71) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (93) | EU/1/20/1442/001-003, 2020-05-20 |
| (95) | Ozanimodas arba jo farmaciniu požiūriu priimtina druska, įskaitant hidrochlorido druską |
| SPC revoked (the basic patent revoked after opposition at the EPO) | ||
| Date of negative decision to issue the SPC | 2024-11-27 |